John C. Jacobs
Board Member
Novavax Inc (NVAX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-07-11–present
-
Current
-
Current
-
Start not stated–2023-01-20
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Novavax Inc (NVAX) | President and CEO | $792,917 | $8,856,015 |
| 2024 | Novavax Inc (NVAX) | President and CEO | $752,500 | $5,087,461 |
| 2023 | Harmony Biosciences Holdings, Inc. (HRMY) | Former President and Former Chief Executive Officer | $29,567 | $36,634 |
| 2023 | Novavax Inc (NVAX) | President and CEO | $662,868 | $7,269,509 |
| 2022 | Harmony Biosciences Holdings, Inc. (HRMY) | Former President and Former Chief Executive Officer | $500,897 | $514,752 |
| 2021 | Harmony Biosciences Holdings, Inc. (HRMY) | Former President and Former Chief Executive Officer | $488,680 | $885,554 |
| 2020 | Harmony Biosciences Holdings, Inc. (HRMY) | President and Chief Executive Officer | $473,068 | $3,230,734 |
| 2019 | Harmony Biosciences Holdings, Inc. (HRMY) | President and Chief Executive Officer | $454,000 | $845,663 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.